Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
To assess the bioequivalence of Fexofenadine Hydrochloride Orally Disintegrating Tablets 30
mg of Dr. Reddy's Laboratories Limited, India comparing with that of Allegra® (containing
fexofenadine hydrochloride) Orally Disintegrating Tablets 30 mg of Sanofi - aventis U.S. LLC,
Bridgewater, NJ 08807 in healthy, adult, human subjects under fasting conditions. To monitor
adverse events and ensure the safety of subjects.